Karyopharm Therapeutics Inc.
KPTI
$1.61
-$0.09-5.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -199.32% | 78.09% | -208.50% | 11.07% | -58.78% |
| Total Depreciation and Amortization | -125.00% | -36.84% | -84.30% | 55.13% | 0.00% |
| Total Amortization of Deferred Charges | 8.26% | -3.39% | -12.93% | 3.24% | 5.71% |
| Total Other Non-Cash Items | 683.23% | -107.96% | 716.63% | 76.82% | 134.28% |
| Change in Net Operating Assets | -66.97% | -29.98% | -61.40% | 41.76% | 759.02% |
| Cash from Operations | -9.69% | -92.15% | -101.84% | 68.66% | 52.04% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -413.63% | -36.00% | 4.06% | -73.72% | 19.60% |
| Cash from Investing | -413.63% | -36.00% | 4.06% | -73.72% | 19.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.86% | 448.69% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -241.53% | 93.33% | -- | -- | -- |
| Cash from Financing | -101.80% | 67.73% | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -300.00% | -60.00% | 150.00% | -75.00% | 60.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -218.47% | 32.39% | 2,271.79% | -2,093.75% | 99.80% |